Review



anti human pedf capture antibody  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    R&D Systems anti human pedf capture antibody
    Quantitative RT-PCR was performed on RPE-choroid samples removed 7 days post laser photocoagulation from control (C57BL/6), CFB−/− (no-AP) and C1q−/− MBL−/− (AP-only) mice. Quantitative values were obtained by cycle number (Ct value), determining the difference between the mean experimental <t>(e.g.,</t> <t>VEGF)</t> and control (β-actin) ΔCt values. With the exception of C3 mRNA expression, mRNA levels for all the angiogenesis (VEGF and <t>PEDF)</t> and complement markers (C9) were normalized in CFB−/− (no-AP) and C1q−/− MBL−/− (AP-only) mice when compared to the C57BL/6 control. No consistent trends were obtained in the membrane-bound complement inhibitors CD55 and CD659 or the soluble inhibitor CFH. Tissues from 3 animals per group were evaluated.
    Anti Human Pedf Capture Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti human pedf capture antibody/product/R&D Systems
    Average 90 stars, based on 4 article reviews
    anti human pedf capture antibody - by Bioz Stars, 2026-02
    90/100 stars

    Images

    1) Product Images from "The alternative pathway is required, but not alone sufficient, for retinal pathology in mouse laser-induced choroidal neovascularization"

    Article Title: The alternative pathway is required, but not alone sufficient, for retinal pathology in mouse laser-induced choroidal neovascularization

    Journal:

    doi: 10.1016/j.molimm.2010.12.016

    Quantitative RT-PCR was performed on RPE-choroid samples removed 7 days post laser photocoagulation from control (C57BL/6), CFB−/− (no-AP) and C1q−/− MBL−/− (AP-only) mice. Quantitative values were obtained by cycle number (Ct value), determining the difference between the mean experimental (e.g., VEGF) and control (β-actin) ΔCt values. With the exception of C3 mRNA expression, mRNA levels for all the angiogenesis (VEGF and PEDF) and complement markers (C9) were normalized in CFB−/− (no-AP) and C1q−/− MBL−/− (AP-only) mice when compared to the C57BL/6 control. No consistent trends were obtained in the membrane-bound complement inhibitors CD55 and CD659 or the soluble inhibitor CFH. Tissues from 3 animals per group were evaluated.
    Figure Legend Snippet: Quantitative RT-PCR was performed on RPE-choroid samples removed 7 days post laser photocoagulation from control (C57BL/6), CFB−/− (no-AP) and C1q−/− MBL−/− (AP-only) mice. Quantitative values were obtained by cycle number (Ct value), determining the difference between the mean experimental (e.g., VEGF) and control (β-actin) ΔCt values. With the exception of C3 mRNA expression, mRNA levels for all the angiogenesis (VEGF and PEDF) and complement markers (C9) were normalized in CFB−/− (no-AP) and C1q−/− MBL−/− (AP-only) mice when compared to the C57BL/6 control. No consistent trends were obtained in the membrane-bound complement inhibitors CD55 and CD659 or the soluble inhibitor CFH. Tissues from 3 animals per group were evaluated.

    Techniques Used: Quantitative RT-PCR, Control, Expressing, Membrane

    Quantitative ELISA assays were performed on RPE-choroid samples removed 7 days post laser photocoagulation from control (C57BL/6), CFB−/− (no-AP) and C1q−/− MBL−/− (AP-only) mice. Quantitative values were obtained by using a standard curve of purified mouse protein (VEGF) or by determining the fold difference between experimental (e.g., CFB−/− and control C57BL/6) values (PEDF). Protein levels for VEGF (A) and PEDF (B) followed the mRNA levels; both were normalized in CFB−/− (no-AP) and C1q−/− MBL−/− (AP-only) mice when compared to the C57BL/6 control. Tissues from 3 animals per group were evaluated.
    Figure Legend Snippet: Quantitative ELISA assays were performed on RPE-choroid samples removed 7 days post laser photocoagulation from control (C57BL/6), CFB−/− (no-AP) and C1q−/− MBL−/− (AP-only) mice. Quantitative values were obtained by using a standard curve of purified mouse protein (VEGF) or by determining the fold difference between experimental (e.g., CFB−/− and control C57BL/6) values (PEDF). Protein levels for VEGF (A) and PEDF (B) followed the mRNA levels; both were normalized in CFB−/− (no-AP) and C1q−/− MBL−/− (AP-only) mice when compared to the C57BL/6 control. Tissues from 3 animals per group were evaluated.

    Techniques Used: Enzyme-linked Immunosorbent Assay, Control, Purification



    Similar Products

    90
    R&D Systems anti human pedf capture antibody
    Quantitative RT-PCR was performed on RPE-choroid samples removed 7 days post laser photocoagulation from control (C57BL/6), CFB−/− (no-AP) and C1q−/− MBL−/− (AP-only) mice. Quantitative values were obtained by cycle number (Ct value), determining the difference between the mean experimental <t>(e.g.,</t> <t>VEGF)</t> and control (β-actin) ΔCt values. With the exception of C3 mRNA expression, mRNA levels for all the angiogenesis (VEGF and <t>PEDF)</t> and complement markers (C9) were normalized in CFB−/− (no-AP) and C1q−/− MBL−/− (AP-only) mice when compared to the C57BL/6 control. No consistent trends were obtained in the membrane-bound complement inhibitors CD55 and CD659 or the soluble inhibitor CFH. Tissues from 3 animals per group were evaluated.
    Anti Human Pedf Capture Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti human pedf capture antibody/product/R&D Systems
    Average 90 stars, based on 1 article reviews
    anti human pedf capture antibody - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    Image Search Results


    Quantitative RT-PCR was performed on RPE-choroid samples removed 7 days post laser photocoagulation from control (C57BL/6), CFB−/− (no-AP) and C1q−/− MBL−/− (AP-only) mice. Quantitative values were obtained by cycle number (Ct value), determining the difference between the mean experimental (e.g., VEGF) and control (β-actin) ΔCt values. With the exception of C3 mRNA expression, mRNA levels for all the angiogenesis (VEGF and PEDF) and complement markers (C9) were normalized in CFB−/− (no-AP) and C1q−/− MBL−/− (AP-only) mice when compared to the C57BL/6 control. No consistent trends were obtained in the membrane-bound complement inhibitors CD55 and CD659 or the soluble inhibitor CFH. Tissues from 3 animals per group were evaluated.

    Journal:

    Article Title: The alternative pathway is required, but not alone sufficient, for retinal pathology in mouse laser-induced choroidal neovascularization

    doi: 10.1016/j.molimm.2010.12.016

    Figure Lengend Snippet: Quantitative RT-PCR was performed on RPE-choroid samples removed 7 days post laser photocoagulation from control (C57BL/6), CFB−/− (no-AP) and C1q−/− MBL−/− (AP-only) mice. Quantitative values were obtained by cycle number (Ct value), determining the difference between the mean experimental (e.g., VEGF) and control (β-actin) ΔCt values. With the exception of C3 mRNA expression, mRNA levels for all the angiogenesis (VEGF and PEDF) and complement markers (C9) were normalized in CFB−/− (no-AP) and C1q−/− MBL−/− (AP-only) mice when compared to the C57BL/6 control. No consistent trends were obtained in the membrane-bound complement inhibitors CD55 and CD659 or the soluble inhibitor CFH. Tissues from 3 animals per group were evaluated.

    Article Snippet: To measure production of VEGF and PEDF by the RPE-choroid, eyecups were solubilized in CellLytic MT (mammalian tissue lysis/extraction reagent; Sigma) and centrifuged at 20,000 g for 5 min. Microplates were coated with either the anti-mouse VEGF (Antigenix America, Inc.) ( Rohrer et al., 2009 ) or the anti-human PEDF capture antibody (R&D Systems, Minneapolis, MN) ( Ma et al., 2009 ), and 100 μL of the tissue extract was added.

    Techniques: Quantitative RT-PCR, Control, Expressing, Membrane

    Quantitative ELISA assays were performed on RPE-choroid samples removed 7 days post laser photocoagulation from control (C57BL/6), CFB−/− (no-AP) and C1q−/− MBL−/− (AP-only) mice. Quantitative values were obtained by using a standard curve of purified mouse protein (VEGF) or by determining the fold difference between experimental (e.g., CFB−/− and control C57BL/6) values (PEDF). Protein levels for VEGF (A) and PEDF (B) followed the mRNA levels; both were normalized in CFB−/− (no-AP) and C1q−/− MBL−/− (AP-only) mice when compared to the C57BL/6 control. Tissues from 3 animals per group were evaluated.

    Journal:

    Article Title: The alternative pathway is required, but not alone sufficient, for retinal pathology in mouse laser-induced choroidal neovascularization

    doi: 10.1016/j.molimm.2010.12.016

    Figure Lengend Snippet: Quantitative ELISA assays were performed on RPE-choroid samples removed 7 days post laser photocoagulation from control (C57BL/6), CFB−/− (no-AP) and C1q−/− MBL−/− (AP-only) mice. Quantitative values were obtained by using a standard curve of purified mouse protein (VEGF) or by determining the fold difference between experimental (e.g., CFB−/− and control C57BL/6) values (PEDF). Protein levels for VEGF (A) and PEDF (B) followed the mRNA levels; both were normalized in CFB−/− (no-AP) and C1q−/− MBL−/− (AP-only) mice when compared to the C57BL/6 control. Tissues from 3 animals per group were evaluated.

    Article Snippet: To measure production of VEGF and PEDF by the RPE-choroid, eyecups were solubilized in CellLytic MT (mammalian tissue lysis/extraction reagent; Sigma) and centrifuged at 20,000 g for 5 min. Microplates were coated with either the anti-mouse VEGF (Antigenix America, Inc.) ( Rohrer et al., 2009 ) or the anti-human PEDF capture antibody (R&D Systems, Minneapolis, MN) ( Ma et al., 2009 ), and 100 μL of the tissue extract was added.

    Techniques: Enzyme-linked Immunosorbent Assay, Control, Purification